1.92
price down icon1.03%   -0.02
pre-market  プレマーケット:  1.90   -0.02   -1.04%
loading
前日終値:
$1.94
開ける:
$1.97
24時間の取引高:
593.76K
Relative Volume:
0.92
時価総額:
$62.71M
収益:
$832.00K
当期純損益:
$-135.12M
株価収益率:
-0.3153
EPS:
-6.09
ネットキャッシュフロー:
$-124.69M
1週間 パフォーマンス:
+12.28%
1か月 パフォーマンス:
+19.25%
6か月 パフォーマンス:
-61.21%
1年 パフォーマンス:
-83.10%
1日の値動き範囲:
Value
$1.86
$1.97
1週間の範囲:
Value
$1.685
$1.97
52週間の値動き範囲:
Value
$1.42
$13.44

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name
名前
Inovio Pharmaceuticals Inc
Name
セクター
Healthcare (1148)
Name
電話
(858) 410-3134
Name
住所
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Name
職員
134
Name
Twitter
@inoviopharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
INO's Discussions on Twitter

INO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INO
Inovio Pharmaceuticals Inc
1.92 62.71M 832.00K -135.12M -124.69M -6.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.00 115.57B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
574.16 60.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
542.47 37.56B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.86 35.18B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
224.73 26.10B 3.81B -644.79M -669.77M -6.24

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-14 開始されました Stephens Overweight
2024-01-25 アップグレード Oppenheimer Perform → Outperform
2022-11-09 ダウングレード Maxim Group Buy → Hold
2022-11-01 ダウングレード BofA Securities Neutral → Underperform
2022-07-19 再開されました RBC Capital Mkts Sector Perform
2022-05-11 ダウングレード Oppenheimer Outperform → Perform
2022-01-21 アップグレード BofA Securities Underperform → Neutral
2021-12-29 再開されました Jefferies Hold
2021-09-10 ダウングレード BofA Securities Neutral → Underperform
2021-06-24 開始されました Jefferies Hold
2021-03-23 開始されました BofA Securities Neutral
2021-02-12 開始されました Oppenheimer Outperform
2020-11-17 ダウングレード ROTH Capital Neutral → Sell
2020-11-10 アップグレード ROTH Capital Sell → Neutral
2020-09-28 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-09-28 アップグレード Maxim Group Hold → Buy
2020-07-01 ダウングレード Maxim Group Buy → Hold
2020-07-01 ダウングレード ROTH Capital Neutral → Sell
2020-06-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-06-26 ダウングレード Stifel Buy → Hold
2020-05-21 開始されました The Benchmark Company Buy
2020-04-30 ダウングレード ROTH Capital Buy → Neutral
2020-03-13 ダウングレード Piper Sandler Overweight → Neutral
2020-03-13 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-12-19 開始されました ROTH Capital Buy
2018-02-15 繰り返されました Maxim Group Buy
2017-10-18 開始されました RBC Capital Mkts Outperform
2017-09-06 開始されました Citigroup Buy
2017-06-08 アップグレード Piper Jaffray Neutral → Overweight
2017-05-24 繰り返されました Maxim Group Buy
2017-03-16 アップグレード Maxim Group Hold → Buy
2017-03-16 ダウングレード Piper Jaffray Overweight → Neutral
すべてを表示

Inovio Pharmaceuticals Inc (INO) 最新ニュース

pulisher
03:15 AM

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ... - Yahoo Finance

03:15 AM
pulisher
May 13, 2025

Inovio Pharmaceuticals (INO) Advances BLA Submission for INO-310 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Inovio’s Q1 2025 sees narrowed losses, stock rises - Investing.com

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Inovio: Q1 Earnings Snapshot - San Francisco Chronicle

May 13, 2025
pulisher
May 13, 2025

INO Reports Strong Q1 Revenue, Progress on INO-3107 Submission | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent B - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings: EPS of -$0.51 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire

May 13, 2025
pulisher
May 13, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Lowered to “Sell” Rating by StockNews.com - Defense World

May 13, 2025
pulisher
May 11, 2025

Inovio Pharmaceuticals (INO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Inovio at The Citizens JMP Life Sciences Conference: DNA Platform Progress - Investing.com Australia

May 08, 2025
pulisher
May 05, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Shares Sold by Renaissance Technologies LLC - Defense World

May 05, 2025
pulisher
May 05, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com - Defense World

May 05, 2025
pulisher
May 03, 2025

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - Kilgore News Herald

May 03, 2025
pulisher
May 02, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

May 02, 2025
pulisher
May 02, 2025

INOVIO to Announce Q1 2025 Results and Host Live Webcast on May 13 - MyChesCo

May 02, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Boosts Stake in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

May 01, 2025
pulisher
May 01, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences - The Bradford Era

May 01, 2025
pulisher
Apr 30, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences | INO Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

XTX Topco Ltd Acquires New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

INOVIO Reveals Breakthrough: DNA Therapy INO-3107 Cuts RRP Surgeries by 81%First Long-Term Data - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

INOVIO Q1 2025 Earnings: DNA Medicine Leader to Reveal Latest Financial Performance May 13 - Stock Titan

Apr 29, 2025
pulisher
Apr 27, 2025

Bank of Montreal Can Makes New $43,000 Investment in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 25, 2025
pulisher
Apr 24, 2025

Inovio Pharmaceuticals Inc. stock rises Thursday, still underperforms market - MarketWatch

Apr 24, 2025
pulisher
Apr 24, 2025

Human Papillomavirus Market Set for Breakthrough Expansion - openPR.com

Apr 24, 2025
pulisher
Apr 23, 2025

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 23, 2025
pulisher
Apr 21, 2025

Bet on These 5 Top-Ranked Stocks With Rising P/E - Nasdaq

Apr 21, 2025
pulisher
Apr 20, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Raised to “Hold” at StockNews.com - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - ADVFN

Apr 17, 2025
pulisher
Apr 17, 2025

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2025
pulisher
Apr 16, 2025

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 16, 2025
pulisher
Apr 11, 2025

Inovio Pharmaceuticals Inc. stock rises Friday, still underperforms market - MarketWatch

Apr 11, 2025
pulisher
Apr 11, 2025

INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

INOVIO to Showcase Breakthrough Data on INO-3107 at Major Industry Conferences - MyChesCo

Apr 11, 2025
pulisher
Apr 10, 2025

Inovio (INO) Upgraded to Buy: Here's What You Should Know - MSN

Apr 10, 2025
pulisher
Apr 10, 2025

INOVIO Reports Inducement Grant Under Inducement Plan - MarketScreener

Apr 10, 2025
pulisher
Apr 10, 2025

Next-generation Covid-19 vaccines currently being tested - Yahoo Finance

Apr 10, 2025
pulisher
Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences | INO Stock News - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

INOVIO to Present at Upcoming Scientific Conferences - Longview News-Journal

Apr 09, 2025
pulisher
Apr 08, 2025

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 08, 2025

Inovio Pharmaceuticals Inc (INO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.71
price down icon 3.01%
$19.31
price down icon 3.11%
$32.82
price down icon 1.59%
$24.61
price down icon 2.57%
$94.50
price down icon 2.85%
biotechnology ONC
$224.73
price down icon 3.65%
大文字化:     |  ボリューム (24 時間):